{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:28:07Z","timestamp":1792801687100,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["16\/2551-0000526-5 (PRONUPEQ)"],"award-info":[{"award-number":["16\/2551-0000526-5 (PRONUPEQ)"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["430841\/2016-7 (Universal)"],"award-info":[{"award-number":["430841\/2016-7 (Universal)"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["150560\/2019\u20132"],"award-info":[{"award-number":["150560\/2019\u20132"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11011-020-00618-y","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T02:02:47Z","timestamp":1602727367000},"page":"153-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis"],"prefix":"10.1007","volume":"36","author":[{"given":"Michelle S.","family":"Antunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Vagner Lobo","family":"Ladd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliny Antunes Barbosa Lobo","family":"Ladd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Lopez","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana Peterini","family":"Boeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0973-1371","authenticated-orcid":false,"given":"Leandro","family":"Cattelan Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"618_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.biopha.2016.11.074","volume":"85","author":"AI Abushouk","year":"2017","unstructured":"Abushouk AI, Negida A, Ahmed H, Abdel-Daim MM (2017) Neuroprotective mechanisms of plant extracts against MPTP induced neurotoxicity: future applications in Parkinson\u2019s disease. Biomed Pharmacother 85:635\u2013645. https:\/\/doi.org\/10.1016\/j.biopha.2016.11.074","journal-title":"Biomed Pharmacother"},{"key":"618_CR2","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.nut.2014.03.024","volume":"30","author":"MS Antunes","year":"2014","unstructured":"Antunes MS, Goes ATR, Boeira SP, Prigol M, Jesse CR (2014) Protective effect of hesperidin in a model of Parkinson\u2019s disease induced by 6-hydroxydopamine in aged mice. Nutrition 30:1415\u20131422. https:\/\/doi.org\/10.1016\/j.nut.2014.03.024","journal-title":"Nutrition"},{"key":"618_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ejphar.2016.07.042","volume":"789","author":"MS Antunes","year":"2016","unstructured":"Antunes MS, Jesse CR, Ruff JR, de Oliveira Espinosa D, Gomes NS, Altvater EET, Donato F, Giacomeli R, Boeira SP (2016) Hesperidin reverses cognitive and depressive disturbances induced by olfactory bulbectomy in mice by modulating hippocampal neurotrophins and cytokine levels and acetylcholinesterase activity. Eur J Pharmacol 789:411\u2013420. https:\/\/doi.org\/10.1016\/j.ejphar.2016.07.042","journal-title":"Eur J Pharmacol"},{"key":"618_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jns.2016.12.060","volume":"373","author":"R Balestrino","year":"2017","unstructured":"Balestrino R, Martinez-Martin P (2017) Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson\u2019s disease. J Neurol Sci 373:173\u2013178. https:\/\/doi.org\/10.1016\/j.jns.2016.12.060","journal-title":"J Neurol Sci"},{"key":"618_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose A, Beal MF (2016) Mitochondrial dysfunction in Parkinson\u2019s disease. J Neurochem 139:216\u2013231. https:\/\/doi.org\/10.1111\/jnc.13731","journal-title":"J Neurochem"},{"key":"618_CR6","doi-asserted-by":"publisher","unstructured":"Carabelas R (2016) Parkinson\u2019s disease: old concepts and new challenges. Alzheimers Dis Dement 1. https:\/\/doi.org\/10.36959\/734\/36","DOI":"10.36959\/734\/36"},{"key":"618_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","volume":"8","author":"KR Chaudhuri","year":"2009","unstructured":"Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464\u2013474. https:\/\/doi.org\/10.1016\/S1474-4422(09)70068-7","journal-title":"Lancet Neurol"},{"key":"618_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/ojapo.2012.11.001","volume":"1","author":"J David Adams Jr","year":"2012","unstructured":"David Adams Jr J (2012) Parkinson\u2019s Disease-Apoptosis and Dopamine Oxidation Open J Apoptosis 1:1\u20138. https:\/\/doi.org\/10.4236\/ojapo.2012.11.001","journal-title":"Parkinson\u2019s Disease-Apoptosis and Dopamine Oxidation Open J Apoptosis"},{"key":"618_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neulet.2019.05.036","volume":"706","author":"L Del Fabbro","year":"2019","unstructured":"Del Fabbro L et al (2019) Chrysin protects against behavioral, cognitive and neurochemical alterations in a 6-hydroxydopamine model of Parkinson\u2019s disease. Neurosci Lett 706:158\u2013163. https:\/\/doi.org\/10.1016\/j.neulet.2019.05.036","journal-title":"Neurosci Lett"},{"key":"618_CR10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0021-9258(18)84756-1","volume":"66","author":"CH Fiske","year":"1925","unstructured":"Fiske CH, Subbarow Y (1925) The colorimetric determination of phosphorus. J Biol Chem 66:375\u2013400","journal-title":"J Biol Chem"},{"key":"618_CR11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ptr.1074","volume":"15","author":"A Garg","year":"2001","unstructured":"Garg A, Garg S, Zaneveld LJD, Singla AK (2001) Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. Phyther Res 15:655\u2013669. https:\/\/doi.org\/10.1002\/ptr.1074","journal-title":"Phyther Res"},{"key":"618_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1734-1140(10)70321-2","volume":"62","author":"V Gaur","year":"2010","unstructured":"Gaur V, Kumar A (2010) Hesperidin pre-treatment attenuates NO-mediated cerebral ischemic reperfusion injury and memory dysfunction. Pharmacol Reports 62:635\u2013648. https:\/\/doi.org\/10.1016\/S1734-1140(10)70321-2","journal-title":"Pharmacol Reports"},{"key":"618_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuroscience.2013.09.042","volume":"256","author":"ATR Goes","year":"2014","unstructured":"Goes ATR, Souza LC, Filho CB, del Fabbro L, de Gomes MG, Boeira SP, Jesse CR (2014) Neuroprotective effects of swimming training in a mouse model of Parkinson\u2019s disease induced by 6-hydroxydopamine. Neuroscience 256:61\u201371. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.09.042","journal-title":"Neuroscience"},{"key":"618_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cbi.2017.10.019","volume":"279","author":"ATR Goes","year":"2018","unstructured":"Goes ATR, Jesse CR, Antunes MS, Lobo Ladd FV, Lobo Ladd AAB, Luchese C, Paroul N, Boeira SP (2018) Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson\u2019s disease: involvement of neuroinflammation and neurotrophins. Chem Biol Interact 279:111\u2013120. https:\/\/doi.org\/10.1016\/j.cbi.2017.10.019","journal-title":"Chem Biol Interact"},{"key":"618_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1432-1033.1974.tb03608.x","volume":"46","author":"DE Griffiths","year":"1974","unstructured":"Griffiths DE, Houghton RL (1974) Studies on energy-linked reactions: modified mitochondrial ATPase of Oligomycin-resistant mutants of Saccharomyces cerevisiae. Eur J Biochem 46:157\u2013167. https:\/\/doi.org\/10.1111\/j.1432-1033.1974.tb03608.x","journal-title":"Eur J Biochem"},{"key":"618_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1046\/j.1365-2818.2002.01054.x","volume":"207","author":"HJG Gundersen","year":"2002","unstructured":"Gundersen HJG (2002) The smooth fractionator. J Microsc 207:191\u2013210. https:\/\/doi.org\/10.1046\/j.1365-2818.2002.01054.x","journal-title":"J Microsc"},{"key":"618_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1699-0463.1988.tb00954.x","volume":"96","author":"HJG Gundersen","year":"1988","unstructured":"Gundersen HJG, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, M\u00d8Ller A, Nielsen K, Nyengaard JR, Pakkenberg B, S\u00d8Rensen FB, Vesterby A, West MJ (1988) The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. Apmis 96:857\u2013881. https:\/\/doi.org\/10.1111\/j.1699-0463.1988.tb00954.x","journal-title":"Apmis"},{"key":"618_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","volume":"51","author":"DN Hauser","year":"2013","unstructured":"Hauser DN, Hastings TG (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease and monogenic parkinsonism. Neurobiol Dis 51:35\u201342. https:\/\/doi.org\/10.1016\/j.nbd.2012.10.011","journal-title":"Neurobiol Dis"},{"key":"618_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.nrleng.2015.06.019","volume":"32","author":"D Hernandez-Baltazar","year":"2017","unstructured":"Hernandez-Baltazar D, Zavala-Flores LM, Villanueva-Olivo A (2017) The 6-hydroxydopamine model and parkinsonian pathophysiology: novel findings in an older model. Neurol 32:533\u2013539. https:\/\/doi.org\/10.1016\/j.nrleng.2015.06.019","journal-title":"Neurol"},{"key":"618_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/108705710200700411","volume":"7","author":"SG Huang","year":"2002","unstructured":"Huang SG (2002) Development of a high throughput screening assay for mitochondrial membrane potential in living cells. J Biomol Screen 7:383\u2013389. https:\/\/doi.org\/10.1177\/108705710200700411","journal-title":"J Biomol Screen"},{"key":"618_CR21","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"618_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/mt.2011.213","volume":"20","author":"SR Kim","year":"2012","unstructured":"Kim SR, Kareva T, Yarygina O, Kholodilov N, Burke RE (2012) AAV transduction of dopamine neurons with constitutively active rheb protects from neurodegeneration and mediates axon regrowth. Mol Ther 20:275\u2013286. https:\/\/doi.org\/10.1038\/mt.2011.213","journal-title":"Mol Ther"},{"key":"618_CR23","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jns.2014.03.028","volume":"340","author":"EA Kozina","year":"2014","unstructured":"Kozina EA, Khakimova GR, Khaindrava VG, Kucheryanu VG, Vorobyeva NE, Krasnov AN, Georgieva SG, Kerkerian-le Goff L, Ugrumov MV (2014) Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism. J Neurol Sci 340:198\u2013207. https:\/\/doi.org\/10.1016\/j.jns.2014.03.028","journal-title":"J Neurol Sci"},{"key":"618_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainres.2012.06.050","volume":"1471","author":"A Kumar","year":"2012","unstructured":"Kumar A, Sharma N, Gupta A, Kalonia H, Mishra J (2012) Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms. Brain Res 1471:13\u201322. https:\/\/doi.org\/10.1016\/j.brainres.2012.06.050","journal-title":"Brain Res"},{"key":"618_CR25","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00702-014-1185-3","volume":"121","author":"A Kupsch","year":"2014","unstructured":"Kupsch A, Schmidt W, Gizatullina Z, Debska-Vielhaber G, Voges J, Striggow F, Panther P, Schwegler H, Heinze HJ, Vielhaber S, Gellerich FN (2014) 6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson\u2019s disease: Respirometric, histological, and behavioral analyses. J Neural Transm 121:1245\u20131257. https:\/\/doi.org\/10.1007\/s00702-014-1185-3","journal-title":"J Neural Transm"},{"key":"618_CR26","doi-asserted-by":"publisher","unstructured":"Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479\u2013489. https:\/\/doi.org\/10.1016\/s0092-8674(00)80434-1","DOI":"10.1016\/s0092-8674(00)80434-1"},{"key":"618_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787\u2013795. https:\/\/doi.org\/10.1038\/nature05292","journal-title":"Nature"},{"key":"618_CR28","doi-asserted-by":"crossref","unstructured":"Lowry OH, Rosenborough NJ, Farr AL, Randall RJ (1951) Protein measurement with folin phenol reagente. J Biol Chem 193:265\u2013275.","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"618_CR29","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1046\/j.1471-4159.1999.0731492.x","volume":"73","author":"A Nishi","year":"1999","unstructured":"Nishi A, Fisone G, Snyder GL, Dulubova I, Aperia A, Nairn AC, Greengard P (1999) Regulation of Na+, K+-ATPase isoforms in rat neostriatum by dopamine and protein kinase C. J Neurochem 73:1492\u20131501","journal-title":"J Neurochem"},{"key":"618_CR30","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0","volume":"366","author":"DE Oorschot","year":"1996","unstructured":"Oorschot DE (1996) Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods. J Comp Neurol 366:580\u2013599","journal-title":"J Comp Neurol"},{"key":"618_CR31","unstructured":"Paxinos G, Franklin, KBJ (2001). The mouse brain in stereotaxic coordinates: second edition (deluxe) by academic press, New York, ISBN 0-12-547637-X"},{"key":"618_CR32","doi-asserted-by":"publisher","unstructured":"Pedersen PL, Greenawalt JW, Reynafarje B, Hullihen J, Decker GL, Soper JW, Bustamente E (1978) Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver-derived tissues. Methods Cell Biol 20:411\u2013481. https:\/\/doi.org\/10.1016\/s0091-679x(08)62030-0","DOI":"10.1016\/s0091-679x(08)62030-0"},{"key":"618_CR33","doi-asserted-by":"publisher","unstructured":"Perier C, Bov\u00e9 J, Wu DC, Dehay B, Choi DK, Jackson-Lewis V, Rathke-Hartlieb S, Bouillet P, Strasser A, Schulz JB, Przedborski S, Vila M (2007) Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson\u2019s disease. Proc Natl Acad Sci U S A 104:8161\u20138166. https:\/\/doi.org\/10.1073\/pnas.0609874104","DOI":"10.1073\/pnas.0609874104"},{"key":"618_CR34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12640-009-9087-0","volume":"17","author":"RDS Prediger","year":"2010","unstructured":"Prediger RDS, Aguiar AS Jr, Rojas-Mayorquin AE, Figueiredo CP, Matheus FC, Ginestet L, Chevarin C, Bel ED, Mongeau R, Hamon M, Lanfumey L, Raisman-Vozari R (2010) Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine in C57BL\/6 mice models early preclinical phase of Parkinson\u2019s disease. Neurotox Res 17:114\u2013129. https:\/\/doi.org\/10.1007\/s12640-009-9087-0","journal-title":"Neurotox Res"},{"key":"618_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3\u201333. https:\/\/doi.org\/10.1016\/S0014-2999(03)01272-X","journal-title":"Eur J Pharmacol"},{"key":"618_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha EM, De Miranda B, Sanders LH (2018) Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurobiol Dis 109:249\u2013257. https:\/\/doi.org\/10.1016\/j.nbd.2017.04.004","journal-title":"Neurobiol Dis"},{"key":"618_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/ana.21291","volume":"63","author":"GW Ross","year":"2008","unstructured":"Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, Launer L, White LR (2008) Association of olfactory dysfunction with risk for future Parkinson\u2019s disease. Ann Neurol 63:167\u2013173. https:\/\/doi.org\/10.1002\/ana.21291","journal-title":"Ann Neurol"},{"key":"618_CR38","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.neuroscience.2004.08.050","volume":"130","author":"C Schmitz","year":"2005","unstructured":"Schmitz C, Hof PR (2005) Design-based stereology in neuroscience. Neuroscience 130:813\u2013831. https:\/\/doi.org\/10.1016\/j.neuroscience.2004.08.050","journal-title":"Neuroscience"},{"key":"618_CR39","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1073\/pnas.76.6.2979","volume":"76","author":"BL Shapiro","year":"1979","unstructured":"Shapiro BL, Feigal RJ, Lam LFH (1979) Mitochondrial NADH dehydrogenase in cystic fibrosis. Proc Natl Acad Sci U S A 76:2979\u20132983. https:\/\/doi.org\/10.1073\/pnas.76.6.2979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"618_CR40","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1089\/neu.2012.2577","volume":"30","author":"LFA Silva","year":"2013","unstructured":"Silva LFA, Hoffmann MS, Gerbatin RR, Fiorin FS, Dobrachinski F, Mota BC, Wouters ATB, Pavarini SP, Soares FAA, Fighera MR, Royes LFF (2013) Treadmill exercise protects against pentylenetetrazol-induced seizures and oxidative stress after traumatic brain injury. J Neurotrauma 30:1278\u20131287. https:\/\/doi.org\/10.1089\/neu.2012.2577","journal-title":"J Neurotrauma"},{"key":"618_CR41","doi-asserted-by":"publisher","unstructured":"Solanki I, Parihar P, Parihar MS (2016) Neurodegenerative diseases: From available treatments to prospective herbal therapy. Neurochem Int 95:100\u2013108. https:\/\/doi.org\/10.1016\/j.neuint.2015.11.001","DOI":"10.1016\/j.neuint.2015.11.001"},{"key":"618_CR42","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1046\/j.1471-4159.2000.0741605.x","volume":"74","author":"R Soto-Otero","year":"2000","unstructured":"Soto-Otero R, M\u00e9ndez-\u00c1lvarez E, Hermida-Ameijeiras \u00c1, Mu\u00f1oz-Pati\u00f1o AM, Labandeira-Garcia JL (2000) Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson\u2019s disease. J Neurochem 74:1605\u20131612. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0741605.x","journal-title":"J Neurochem"},{"key":"618_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0076-6879(90)82018-W","volume":"182","author":"B Storrie","year":"1990","unstructured":"Storrie B, Madden EA (1990) Isolation of subcellular organelles. Methods Enzymol 182:203\u2013225. https:\/\/doi.org\/10.1016\/0076-6879(90)82018-W","journal-title":"Methods Enzymol"},{"key":"618_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","volume":"82","author":"U Ungerstedt","year":"1971","unstructured":"Ungerstedt U (1971) Postsynaptic Supersensitivity after 6-Hydroxy-dopamine induced degeneration of the Nigrostriatal dopamine system. Acta Physiol Scand 82:69\u201393. https:\/\/doi.org\/10.1111\/j.1365-201X.1971.tb11000.x","journal-title":"Acta Physiol Scand"},{"key":"618_CR45","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/WNR.0000000000000218","volume":"25","author":"P Valle-Leija","year":"2014","unstructured":"Valle-Leija P, Drucker-Col\u00edn R (2014) Unilateral olfactory deficit in a hemiparkinson\u2019s disease mouse model. Neuroreport 25:948\u2013953. https:\/\/doi.org\/10.1097\/WNR.0000000000000218","journal-title":"Neuroreport"},{"key":"618_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12263-008-0091-4","volume":"3","author":"D Vauzour","year":"2008","unstructured":"Vauzour D, Vafeiadou K, Rodriguez-Mateos A, Rendeiro C, Spencer JPE (2008) The neuroprotective potential of flavonoids: a multiplicity of effects. Genes Nutr 3:115\u2013126. https:\/\/doi.org\/10.1007\/s12263-008-0091-4","journal-title":"Genes Nutr"},{"key":"618_CR47","doi-asserted-by":"publisher","unstructured":"Vianello R, Domene C, Mavri J (2016) The use of multiscale molecular simulations in understanding a relationship between the structure and function of biological systems of the brain: the application to monoamine oxidase enzymes. Front Neurosci 10:327. https:\/\/doi.org\/10.3389\/fnins.2016.00327","DOI":"10.3389\/fnins.2016.00327"},{"key":"618_CR48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bbr.2011.03.049","volume":"222","author":"JM Walker","year":"2011","unstructured":"Walker JM, Fowler SW, Miller DK, Sun AY, Weisman GA, Wood WG, Sun GY, Simonyi A, Schachtman TR (2011) Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer\u2019s disease. Behav Brain Res 222:169\u2013175. https:\/\/doi.org\/10.1016\/j.bbr.2011.03.049","journal-title":"Behav Brain Res"},{"key":"618_CR49","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1242\/jcs.00420","volume":"116","author":"XQ Wang","year":"2003","unstructured":"Wang XQ et al (2003) Apoptotic insults impair Na+, K+-ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress. J Cell Sci 116:2099\u20132110. https:\/\/doi.org\/10.1242\/jcs.00420","journal-title":"J Cell Sci"},{"key":"618_CR50","doi-asserted-by":"publisher","first-page":"648740","DOI":"10.1155\/2014\/648740","volume":"2014","author":"A Xie","year":"2014","unstructured":"Xie A, Gao J, Xu L, Meng D (2014) Shared mechanisms of neurodegeneration in alzheimer\u2019s disease and parkinson\u2019s disease. Biomed Res Int 2014:648740\u2013648748. https:\/\/doi.org\/10.1155\/2014\/648740","journal-title":"Biomed Res Int"},{"key":"618_CR51","doi-asserted-by":"publisher","unstructured":"Yang C, Garrett-Mayer E, Schneider JS, Gollomp SM, Tilley BC (2009) Repeatable battery for assessment of neuropsychological status in early Parkinson\u2019s disease. Mov Disord 24:1453\u20131460. https:\/\/doi.org\/10.1002\/mds.22552","DOI":"10.1002\/mds.22552"},{"key":"618_CR52","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.brainres.2015.12.035","volume":"1633","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Hou L, Li X, Ju C, Zhang J, Li X, Wang X, Liu C, Lv Y, Wang Y (2016) Neuroprotection of inositol hexaphosphate and changes of mitochondrion mediated apoptotic pathway and \u03b1-synuclein aggregation in 6-OHDA induced Parkinson\u2019s disease cell model. Brain Res 1633:87\u201395. https:\/\/doi.org\/10.1016\/j.brainres.2015.12.035","journal-title":"Brain Res"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00618-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-020-00618-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00618-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T03:41:34Z","timestamp":1634269294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-020-00618-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1007\/s11011-020-00618-y","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]},"assertion":[{"value":"7 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}